Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The non-coding 3'-untranslated region (UTR) plays an important role in the regulation of microRNA (miRNA) functions, since it can bind and inactivate multiple miRNAs. Here, we show the 3'-UTR of CD44 is able to antagonize cytoplasmic miRNAs, and result in the increased translation of CD44 and downstream target mRNA, CDC42. A series of cell function assays in the human breast cancer cell line, MT-1, have shown that the CD44 3'-UTR inhibits proliferation, colony formation and tumor growth. Furthermore, it modulated endothelial cell activities, favored angiogenesis, induced tumor cell apoptosis and increased sensitivity to Docetaxel. These results are due to the interaction of the CD44 3'-UTR with multiple miRNAs. Computational algorithms have predicted three miRNAs, miR-216a, miR-330 and miR-608, can bind to both the CD44 and CDC42 3'-UTRs. This was confirmed with luciferase assays, western blotting and immunohistochemical staining and correlated with a series of siRNA assays. Thus, the non-coding CD44 3'-UTR serves as a competitor for miRNA binding and subsequently inactivates miRNA functions, by freeing the target mRNAs from being repressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991
Cited by
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
“, 2009), CD44 3’UTR (Jeyapalan et al., 2010)].”
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
Endogenous microRNA sponges: evidence and controversy
Thomson, D. W., & Dinger, M. E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.20 · Cited by 2,185
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw027 · Cited by 1,699
“Cell number was determined by a coulter counter as described (18,19).”
MethodSelf-citationceRNA in cancer: possible functions and clinical implications
Qi, X., Zhang, D.-H., Wu, N., Xiao, J.-H., Wang, X., & Ma, W. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103334 · Cited by 1,271
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.029 · Cited by 1,019
ceRNA Cross-Talk in Cancer: When ce-bling Rivalries Go Awry
Karreth, F. A., & Pandolfi, P. P. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0202 · Cited by 851
Assessing the ceRNA Hypothesis with Quantitative Measurements of miRNA and Target Abundance
Denzler, R., Agarwal, V., Stefano, J., Bartel, D. P., & Stoffel, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.045 · Cited by 713
Sumazin, P., Yang, X., Chiu, H.-S., Chung, W.-J., Iyer, A., Llobet-Navas, D., Rajbhandari, P., Bansal, M., Guarnieri, P., Silva, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.041 · Cited by 697
Liang, W.-C., Fu, W.-M., Wong, C.-W., Wang, Y., Wang, W.-M., Hu, G.-X., Zhang, L., Xiao, L.-J., Wan, D. C.-C., Zhang, J.-F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4154 · Cited by 571
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
Chen, L., Zhang, S., Wu, J., Cui, J., Zhong, L., Zeng, L., & Ge, S. (2017) · Oncogene · doi:10.1038/onc.2017.89 · Cited by 392
RetractedLong noncoding RNA associated-competing endogenous RNAs in gastric cancer
Xia, T., Liao, Q., Jiang, X., Shao, Y., Xiao, B., Xi, Y., & Guo, J. (2014) · Scientific Reports · doi:10.1038/srep06088 · Cited by 388
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
He, R., Liu, P., Xie, X., Zhou, Y., Liao, Q., Xiong, W., Li, X., Li, G., Zeng, Z., & Tang, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0614-1 · Cited by 347
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue
Zhou, R.-S., Zhang, E.-X., Sun, Q.-F., Ye, Z.-J., Liu, J.-W., Zhou, D.-H., & Tang, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5983-8 · Cited by 336
Ala, U., Karreth, F. A., Bosia, C., Pagnani, A., Taulli, R., Léopold, V., Tay, Y., Provero, P., Zecchina, R., & Pandolfi, P. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222509110 · Cited by 332
Yang, W., Du, W. W., Li, X., Yee, A. J., & Yang, B. B. (2016) · Oncogene · doi:10.1038/onc.2015.460 · Cited by 315
Self-citationCompeting Endogenous RNA: The Key to Posttranscriptional Regulation
Sen, R., Ghosal, S., Das, S., Balti, S., & Chakrabarti, J. (2014) · The Scientific World Journal · doi:10.1155/2014/896206 · Cited by 313
Transcriptome-wide miR-155 Binding Map Reveals Widespread Noncanonical MicroRNA Targeting
Loeb, G. B., Khan, A. A., Canner, D., Hiatt, J. B., Shendure, J., Darnell, R. B., Leslie, C. S., & Rudensky, A. Y. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.10.002 · Cited by 311
“…recent work suggested a model in which RNAs compete for miRNA-AGO complexes and reduce repression of other RNAs bearing sites for the same miRNAs (Cesana et al., 2011; Jeyapalan et al., 2011; Karreth et al., 2011; Lee et al., 2009; Poliseno et al., 2010; Sumazin et al., 2011; Tay et al., 2011).”
BackgroundInfluentialUnderstanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
RNA–RNA interactions in gene regulation: the coding and noncoding players
Guil, S., & Esteller, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.001 · Cited by 264
Yang, Z.-G., Awan, F. M., Du, W. W., Zeng, Y., Lyu, J., Wu, D., Gupta, S., Yang, W., & Yang, B. B. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.022 · Cited by 263
Self-citationAbdollahzadeh, R., Daraei, A., Mansoori, Y., Sepahvand, M., Amoli, M. M., & Tavakkoly‐Bazzaz, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27941 · Cited by 261
Pseudogenes: newly discovered players in human cancer.
Poliseno, L. (2012) · Science Signaling · doi:10.1126/scisignal.2002858 · Cited by 170
Li, H., & Yang, B. B. (2012) · Oncotarget · doi:10.18632/oncotarget.810 · Cited by 117
Self-citationAnti-microRNA-378a Enhances Wound Healing Process by Upregulating Integrin Beta-3 and Vimentin
Li, H., Chang, L., Du, W. W., Gupta, S., Khorshidi, A., Sefton, M., & Yang, B. B. (2014) · Molecular Therapy · doi:10.1038/mt.2014.115 · Cited by 54
Self-citation
Metadata
- Authors
- Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C., & Yang, B. B.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-10
- Volume
- 39
- Issue
- 8
- Pages
- 3026-3041
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2017768662
- Cited by
- 193
- References
- 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.